Viracta Therapeutics, Inc. (VIRX)
NASDAQ: VIRX · IEX Real-Time Price · USD
0.548
-0.003 (-0.45%)
At close: Jul 19, 2024, 4:00 PM
0.550
+0.003 (0.46%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Viracta Therapeutics Stock Forecast
VIRX's stock price has decreased by -65.35% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for VIRX stock have an average target of 7.20, with a low estimate of 4.00 and a high estimate of 11. The average target predicts an increase of 1,215.07% from the current stock price of 0.55.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 23, 2024.
Analyst Ratings
The average analyst rating for VIRX stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $13 → $11 | Buy | Maintains | $13 → $11 | +1,909.13% | May 23, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $13 | Buy | Maintains | $13 | +2,274.43% | Apr 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +630.59% | Apr 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +630.59% | Mar 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $4 | Strong Buy | Maintains | $10 → $4 | +630.59% | Jan 5, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
2.38M
EPS This Year
-1.18
from -1.32
EPS Next Year
-1.12
from -1.18
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 7.4M | 47.0M | 59.7M | 129.6M |
| Avg | n/a | 2.4M | 20.6M | 58.0M | 125.9M |
| Low | n/a | n/a | n/a | 55.6M | 120.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 1,874.0% | 189.8% | 123.5% |
| Avg | - | - | 766.3% | 181.1% | 117.1% |
| Low | - | - | - | 169.8% | 108.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.10 | -0.96 | -0.91 | -0.91 | -0.20 |
| Avg | -1.18 | -1.12 | -1.28 | -0.90 | -0.19 |
| Low | -1.23 | -1.30 | -1.51 | -0.88 | -0.19 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.